Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)

Yee Kit Tai; Karen Ka Wing Chan; Charlene Hui Hua Fong; Sharanya Ramanan; Jasmine Lye Yee Yap; Jocelyn Naixin Yin; Yun Sheng Yip; Wei Ren Tan; Angele Pei Fern Koh; Nguan Soon Tan; Ching Wan Chan; Ruby Yun Ju Huang; Jing Ze Li; Jürg Fröhlich; Alfredo Franco-Obregón

doi:10.3389/fonc.2022.892408

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)

Yee Kit Tai, Karen Ka Wing Chan, Charlene Hui Hua Fong, Sharanya Ramanan, Jasmine Lye Yee Yap, Jocelyn Naixin Yin, Yun Sheng Yip, Wei Ren Tan, Angele Pei Fern Koh, Nguan Soon Tan, Ching Wan Chan, Ruby Yun Ju Huang, Jing Ze Li, Jürg Fröhlich, Alfredo Franco-Obregón^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original article, there was a nonconsequential error in Figure 1 as published. A fileconcatenation error occurred within the FACS analysis software that implicated the scatter dotplots shown in Figure 1C. The corrected Figure 1 appears below.

Original language	English
Article number	892408
Journal	Frontiers in Oncology
Volume	12
DOIs	https://doi.org/10.3389/fonc.2022.892408
Publication status	Published - Apr 20 2022
Externally published	Yes

Bibliographical note

Publisher Copyright:
Copyright © 2022 Tai, Chan, Fong, Ramanan, Yap, Yin, Yip, Tan, Koh, Tan, Chan, Huang, Li, Fröhlich and Franco-Obregón.

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

breast cancer
chemotherapy
chorioallantoic membrane
doxorubicin
EMT
patient-derived xenograft
PEMFs
TRPC1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2022.892408

Fingerprint

Dive into the research topics of 'Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)'. Together they form a unique fingerprint.

Cite this

Tai, Y. K., Chan, K. K. W., Fong, C. H. H., Ramanan, S., Yap, J. L. Y., Yin, J. N., Yip, Y. S., Tan, W. R., Koh, A. P. F., Tan, N. S., Chan, C. W., Huang, R. Y. J., Li, J. Z., Fröhlich, J., & Franco-Obregón, A. (2022). Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803). Frontiers in Oncology, 12, Article 892408. https://doi.org/10.3389/fonc.2022.892408

@article{9cb65e6cf2b149cfbd5ab1a45ddfefbe,

title = "Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)",

abstract = "In the original article, there was a nonconsequential error in Figure 1 as published. A fileconcatenation error occurred within the FACS analysis software that implicated the scatter dotplots shown in Figure 1C. The corrected Figure 1 appears below.",

keywords = "breast cancer, chemotherapy, chorioallantoic membrane, doxorubicin, EMT, patient-derived xenograft, PEMFs, TRPC1",

author = "Tai, {Yee Kit} and Chan, {Karen Ka Wing} and Fong, {Charlene Hui Hua} and Sharanya Ramanan and Yap, {Jasmine Lye Yee} and Yin, {Jocelyn Naixin} and Yip, {Yun Sheng} and Tan, {Wei Ren} and Koh, {Angele Pei Fern} and Tan, {Nguan Soon} and Chan, {Ching Wan} and Huang, {Ruby Yun Ju} and Li, {Jing Ze} and J{\"u}rg Fr{\"o}hlich and Alfredo Franco-Obreg{\'o}n",

note = "Publisher Copyright: Copyright {\textcopyright} 2022 Tai, Chan, Fong, Ramanan, Yap, Yin, Yip, Tan, Koh, Tan, Chan, Huang, Li, Fr{\"o}hlich and Franco-Obreg{\'o}n.",

year = "2022",

month = apr,

day = "20",

doi = "10.3389/fonc.2022.892408",

language = "English",

volume = "12",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

Tai, YK, Chan, KKW, Fong, CHH, Ramanan, S, Yap, JLY, Yin, JN, Yip, YS, Tan, WR, Koh, APF, Tan, NS, Chan, CW, Huang, RYJ, Li, JZ, Fröhlich, J & Franco-Obregón, A 2022, 'Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)', Frontiers in Oncology, vol. 12, 892408. https://doi.org/10.3389/fonc.2022.892408

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803). / Tai, Yee Kit; Chan, Karen Ka Wing; Fong, Charlene Hui Hua et al.
In: Frontiers in Oncology, Vol. 12, 892408, 20.04.2022.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum

T2 - Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)

AU - Tai, Yee Kit

AU - Chan, Karen Ka Wing

AU - Fong, Charlene Hui Hua

AU - Ramanan, Sharanya

AU - Yap, Jasmine Lye Yee

AU - Yin, Jocelyn Naixin

AU - Yip, Yun Sheng

AU - Tan, Wei Ren

AU - Koh, Angele Pei Fern

AU - Tan, Nguan Soon

AU - Chan, Ching Wan

AU - Huang, Ruby Yun Ju

AU - Li, Jing Ze

AU - Fröhlich, Jürg

AU - Franco-Obregón, Alfredo

PY - 2022/4/20

Y1 - 2022/4/20

N2 - In the original article, there was a nonconsequential error in Figure 1 as published. A fileconcatenation error occurred within the FACS analysis software that implicated the scatter dotplots shown in Figure 1C. The corrected Figure 1 appears below.

AB - In the original article, there was a nonconsequential error in Figure 1 as published. A fileconcatenation error occurred within the FACS analysis software that implicated the scatter dotplots shown in Figure 1C. The corrected Figure 1 appears below.

KW - breast cancer

KW - chemotherapy

KW - chorioallantoic membrane

KW - doxorubicin

KW - EMT

KW - patient-derived xenograft

KW - PEMFs

KW - TRPC1

UR - http://www.scopus.com/inward/record.url?scp=85129541364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129541364&partnerID=8YFLogxK

U2 - 10.3389/fonc.2022.892408

DO - 10.3389/fonc.2022.892408

M3 - Comment/debate

AN - SCOPUS:85129541364

SN - 2234-943X

VL - 12

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 892408

ER -

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach(Front. Oncol., (2022), 11, (783803), 10.3389/fonc.2021.783803)

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this